Our Opinion
CytoMed Therapeutics Limited is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.
Supporting Evidence:
The company stated in the following report that they exploit animals for product testing.
“To evaluate the cytotoxicity of CTM-N2D in vivo, a xenograft mouse model was established using human ovarian cancer cell line SKOV3 in non-obese diabetic scid gamma mice. Seven days later, 1×107 cells of CTM-N2D were given as treatment twice a week for a total of 3 weeks.” (Page 63) Read the full document
Company Description
CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. The company was incorporated in 2018 and is headquartered in Singapore.
Company Website: https://w2.cytomed.sg